Paper35213635
Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach.
Beig Parikhani A and 10 others. PLoS One, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach. Papers, record 35213635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35213635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-2 Receptor alpha Subunit | Major topic |
| Leukocytes, Mononuclear | Major topic |
| Molecular Docking Simulation | Major topic |
| Molecular Dynamics Simulation | Major topic |
| Static Electricity | Major topic |
| Humans | |
| Interleukin-2 | |
| Protein Binding |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23677467 | Human IL-2 mutein with higher antitumor efficacy than wild type IL-2. | J Immunol | 2013 | https://conductscience.org/library/papers/23677467 | PubMed |
| 2 | 27650575 | Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy. | Nat Commun | 2016 | https://conductscience.org/library/papers/27650575 | PubMed |
| 3 | 31462678 | A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control. | Nat Commun | 2019 | https://conductscience.org/library/papers/31462678 | PubMed |
| 4 | 27697858 | IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation. | Cancer Immunol Res | 2016 | https://conductscience.org/library/papers/27697858 | PubMed |
| 5 | 1282065 | Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination. | Leuk Lymphoma | 1992 | https://conductscience.org/library/papers/1282065 | PubMed |
| 6 | 26572555 | Interleukin-2: Biology, Design and Application. | Trends Immunol | 2015 | https://conductscience.org/library/papers/26572555 | PubMed |
| 7 | 29854806 | Prospects of IL-2 in Cancer Immunotherapy. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29854806 | PubMed |
| 8 | 23611462 | Molecular dynamics simulation by GROMACS using GUI plugin for PyMOL. | J Chem Inf Model | 2013 | https://conductscience.org/library/papers/23611462 | PubMed |
| 9 | 23352221 | Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. | Immunity | 2013 | https://conductscience.org/library/papers/23352221 | PubMed |
| 10 | 16505437 | Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16505437 | PubMed |
| 11 | 24907378 | IL-2: the first effective immunotherapy for human cancer. | J Immunol | 2014 | https://conductscience.org/library/papers/24907378 | PubMed |
| 12 | 18996896 | PDBsum new things. | Nucleic Acids Res | 2009 | https://conductscience.org/library/papers/18996896 | PubMed |
| 13 | 23818175 | Motional timescale predictions by molecular dynamics simulations: case study using proline and hydroxyproline sidechain dynamics. | Proteins | 2014 | https://conductscience.org/library/papers/23818175 | PubMed |
| 14 | 8744570 | VMD: visual molecular dynamics. | J Mol Graph | 1996 | https://conductscience.org/library/papers/8744570 | PubMed |
| 15 | 9670041 | CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. | J Exp Med | 1998 | https://conductscience.org/library/papers/9670041 | PubMed |
| 16 | 24410537 | Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy. | Expert Rev Clin Immunol | 2014 | https://conductscience.org/library/papers/24410537 | PubMed |
| 17 | 20547866 | Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20547866 | PubMed |
| 18 | 9504803 | SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. | Electrophoresis | 1997 | https://conductscience.org/library/papers/9504803 | PubMed |
| 19 | 23407358 | GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23407358 | PubMed |
| 20 | 7842289 | Induction of lymphokine-activated killing with reduced secretion of interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma by interleukin-2 analogs. | Ann Surg Oncol | 1994 | https://conductscience.org/library/papers/7842289 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40201389 | Cytokine Couture: Designer IL2 Molecules for the Treatment of Disease. | Immunotargets Ther | 2025 | https://conductscience.org/library/papers/40201389 | PubMed |
| 39425027 | Hypothetical proteins of chicken-isolated Limosilactobacillus reuteri subjected to in silico analyses induce IL-2 and IL-10. | Genes Nutr | 2024 | https://conductscience.org/library/papers/39425027 | PubMed |
| 38482625 | Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its In vitro Antitumor Activity. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38482625 | PubMed |
| 38337114 | A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. | AMB Express | 2024 | https://conductscience.org/library/papers/38337114 | PubMed |
| 37430135 | Comparison of the effects of probiotic strains (Lactobacillus gasseri, Lactiplantibacillus plantarum, Lactobacillus acidophilus, and Limosilactobacillus fermentum) isolated from human and food products on the immune response of CT26 tumor-bearing mice. | Braz J Microbiol | 2023 | https://conductscience.org/library/papers/37430135 | PubMed |
| 36873499 | The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies. | Heliyon | 2023 | https://conductscience.org/library/papers/36873499 | PubMed |
| 35354847 | Efficacy and antitumor activity of a mutant type of interleukin 2. | Sci Rep | 2022 | https://conductscience.org/library/papers/35354847 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| IL2RB | 3560 | PubTator's text mining | https://conductscience.org/library/genes/3560 | NCBI Gene |
| IL2RG | 3561 | PubTator's text mining | https://conductscience.org/library/genes/3561 | NCBI Gene |
| RELA | 5970 | PubTator's text mining | https://conductscience.org/library/genes/5970 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35213635
GET https://conductscience.org/api/papers/v1/35213635/references?page=2